Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates
about
Modified heat-stable toxins (hSTa) of enterotoxigenic Escherichia coli lose toxicity but display antigenicity after being genetically fused to heat-labile toxoid LT(R192G).Functional group/guild modelling of inter-specific pathogen interactions: a potential tool for predicting the consequences of co-infection.Identification of Rotavirus VP6-Specific CD4+ T Cell Epitopes in a G1P[8] Human Rotavirus-Infected Rhesus Macaque.Th17 cytokines and vaccine-induced immunity.Genetic fusions of heat-labile toxoid (LT) and heat-stable toxin b (STb) of porcine enterotoxigenic Escherichia coli elicit protective anti-LT and anti-STb antibodies.Yersinia enterocolitica promotes robust mucosal inflammatory T-cell immunity in murine neonatesNucleoprotein nanostructures combined with adjuvants adapted to the neonatal immune context: a candidate mucosal RSV vaccine.A gastrointestinal rotavirus infection mouse model for immune modulation studies.IL-17A expression in HIV-specific CD8 T cells is regulated by IL-4/IL-13 following HIV-1 prime-boost immunization.Qualitative and quantitative characteristics of rotavirus-specific CD8 T cells vary depending on the route of infection.Why does the world need another rotavirus vaccine?Rotavirus vaccines: how they work or don't work.Safety and efficacy of neonatal vaccination.Prevention of the murine model of biliary atresia after live rotavirus vaccination of dams.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.The neonatal immune system: immunomodulation of infections in early life.Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G).A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.Rotavirus infection.Immunomodulatory Effects of Adjuvants CPG, MPLA, and BCG on the Derp2-Induced Acute Asthma at Early Life in an Animal Model of BALB/c Mice.
P2860
Q30429806-B48CF682-60F5-43FE-9B43-88BAEA279878Q33334278-EE16DF3F-FEF5-4823-AE4D-252DB10AF241Q33791546-12105083-06C9-4E6C-A453-5BD56943B39AQ33792227-74EFB096-199D-4561-A14B-9726079D8DEFQ34045002-20917A72-FB78-450E-971B-D0C40B7D736AQ34045124-F0819234-85CB-4B4A-A4DE-971E5AE330D2Q34289051-F1539FBF-0A60-4DA7-94A6-BE7037DC1672Q34704839-06CE3F80-A422-4162-8F9C-6BCDFEB71185Q35149947-79680462-06A2-4FE8-95FD-40B0AC3DACD8Q36747697-D1FFD85A-D5A3-4F2D-84FD-B0E7CC4CD03DQ36822928-59970D89-235E-4C0E-98D9-ECA62DDEF1F4Q37081817-150C7D13-4F0D-4A9C-BD0C-D79301490C0FQ37336304-4F76B6D9-6A4D-4C1B-B1D8-DD394B77887BQ37357576-DD0F8252-8357-4B8E-A293-07EA9B525E2FQ37951525-81803E19-8FD0-4C7A-A8EF-98AC1D287F10Q38161438-4E07514D-59E6-4E17-AE4E-8F6D07BF121CQ39014478-060B9FD3-892D-4503-8DDF-E09F381EAEEBQ42797127-A0375040-2064-485D-88FC-807B47766B7EQ45362011-26E37761-4FA0-495C-A988-B7D71092717FQ46152582-937208C1-E333-4E3A-9FF1-7F266C4921DCQ52819077-FFB9CB13-EEFF-4CF3-8A26-03AB6965B234
P2860
Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Mice develop effective but del ...... anasally with nonliving VP6/LT
@nl
Mice develop effective but del ...... s rotavirus vaccine candidates
@ast
Mice develop effective but del ...... s rotavirus vaccine candidates
@en
type
label
Mice develop effective but del ...... anasally with nonliving VP6/LT
@nl
Mice develop effective but del ...... s rotavirus vaccine candidates
@ast
Mice develop effective but del ...... s rotavirus vaccine candidates
@en
prefLabel
Mice develop effective but del ...... anasally with nonliving VP6/LT
@nl
Mice develop effective but del ...... s rotavirus vaccine candidates
@ast
Mice develop effective but del ...... s rotavirus vaccine candidates
@en
P2093
P2860
P1433
P1476
Mice develop effective but del ...... s rotavirus vaccine candidates
@en
P2093
Anne E Prada
Anthony H-C Choi
Bert Huffer
John D Clements
John L VanCott
Judy A Bean
Kristi L Smiley
Mingyuan Shao
Mitali Basu
Monica M McNeal
P2860
P304
P356
10.1128/JVI.80.10.4949-4961.2006
P407
P577
2006-05-01T00:00:00Z